Last reviewed · How we verify

NCT05500209

Chatbot-based Internet Intervention for Stress Among University Students (Stressbot)

Completed NA Last updated 1 February 2023
What this trial tests

NA trial testing Personal resources' enhancement: self-efficacy in Stress, Psychological in 372 participants. Completed in 13 November 2022.

Timeline
10 October 2022
Primary endpoint
13 November 2022
13 November 2022

Quick facts

Lead sponsorUniversity of Social Sciences and Humanities, Warsaw
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment372
Start date10 October 2022
Primary completion13 November 2022
Estimated completion13 November 2022
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

University of Social Sciences and Humanities, Warsaw

Who can join

18 and older, any sex, with Stress, Psychological. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to verify the efficacy of chatbot internet intervention for reduction of stress and improvement of quality of life among university students through the enhancement of coping self-efficacy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Low-effort internet intervention to reduce students' stress delivered with Meta's Messenger chatbot (Stressbot): A randomized controlled trial.
    Maciejewski J, Smoktunowicz E. · · 2023 · cited 9× · PMID 37575678 · DOI 10.1016/j.invent.2023.100653

Verify or expand the search:

Other trials of Personal resources' enhancement: self-efficacy

Trials testing the same drug.

Other recruiting trials for Stress, Psychological

Currently open trials in the same condition.

Other University of Social Sciences and Humanities, Warsaw trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05500209.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing